Developing basic technology for personalized medicine: Dr. Paidi Yella Reddy, Founder & CEO, Sapala Organics
Developing basic technology for personalized medicine: Dr. Paidi Yella Reddy, Sapala Organics
Developing basic technology for personalized medicine: Dr. Paidi Yella Reddy, Sapala Organics
The next-generation proteomics platform powered by Olink™ Explore HT enables simultaneous analysis of thousands of proteins from a single sample
Access to genomic testing, not therapy cost, is the biggest challenge
Expands manufacturing push & locks in major growth deals
The combined offering is designed to support a wide range of applications, from pilot-scale research to high-volume clinical use
Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research
There are limited treatment options available for patients living with non-diabetic CKD, and the unmet need is high for new treatments to delay kidney disease progression and reduce cardiovascular risk
OncoMate MSI Dx Analysis System is a PCR-based assay designed to evaluate MSI status in tumor tissue
Subscribe To Our Newsletter & Stay Updated